Health Center 4, Affiliate Diagnostic Center

Riga LV1003

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Psoriasis, Ulcerative Colitis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) — Completed
• The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis — Completed
• Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC — Stopped early